Renal Macrocystic Disease
Gene: SEC16B
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Polycystic liver disease (with or without kidney cysts), MONDO:0000447, SEC16B-related
CLINGEN assessed as LIMITED (2020)
No further evidence since for kidney cysts
SEC61B was first reported in relation to autosomal dominant polycystic liver disease in 2017 (Besse et al., PMID:28375157). At least 2 variants (frameshift, start-loss) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 2 probands in 1 publication (PMID:28375157). This gene-disease association is supported by in vitro functional assays. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.
Sources: Expert ReviewCreated: 25 Nov 2022, 1:53 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Polycystic liver disease with or without renal cysts, no OMIM #
Publications
Gene: sec16b has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: SEC16B were changed from Polycystic liver disease with or without renal cysts, no OMIM # to Polycystic liver disease (with or without kidney cysts), MONDO:0000447, SEC16B-related
Gene: sec16b has been classified as Amber List (Moderate Evidence).
gene: SEC16B was added gene: SEC16B was added to Renal Macrocystic Disease. Sources: Expert Review Mode of inheritance for gene: SEC16B was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SEC16B were set to PMID: 28375157, 28862642, 30652979 Phenotypes for gene: SEC16B were set to Polycystic liver disease with or without renal cysts, no OMIM # Review for gene: SEC16B was set to RED